SAN DIEGO (AP) _ Apricus Biosciences Inc. (APRI) on Monday reported a loss of $300,000 in its fourth quarter.
On a per-share basis, the San Diego-based company said it had a loss of 4 cents.
The drugmaker posted revenue of $400,000 in the period.
For the year, the company reported that its loss narrowed to $7.4 million, or $1.14 per share. Revenue was reported as $5.8 million.
In the final minutes of trading on Monday, the company's shares hit $2.83. A year ago, they were trading at $10.45.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on APRI at https://www.zacks.com/ap/APRI
Keywords: Apricus Biosciences, Earnings Report